Nicolae Bacalbasa1,2, Camelia Diaconu3,4, Cornel Savu5,6, Carmen Savu7, Ovidiu Stiru8,9, Irina Balescu10. 1. Department of Visceral Surgery, Center of Excellence in Translational Medicine "Fundeni" Clinical Institute, Bucharest, Romania; nicolae_bacalbasa@yahoo.ro. 2. Department of Obstetrics and Gynecology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. 3. Department of Internal Medicine, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. 4. Department of Internal Medicine, Clinical Emergency Hospital of Bucharest, Bucharest, Romania. 5. Department of Thoracic Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. 6. Department of Thoracic Surgery, Marius Nasta Institute of Pneumonology, Bucharest, Romania. 7. Department of Anesthesiology, "Fundeni" Clinical Institute, Bucharest, Romania. 8. Department of Cardiovascular Surgery, Prof. Dr. C. C. Iliescu Emergency Institute for Cardiovascular Diseases, Bucharest, Romania. 9. Department of Cardiovascular Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. 10. Department of Surgery, "Ponderas" Academic Hospital, Bucharest, Romania.
Abstract
BACKGROUND/AIM: The aim of this study is to report a case series of three patients who developed postoperative severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) infection, although the initial tests were negative. PATIENTS AND METHODS: Between April and September 2020, three patients submitted to pancreatoduodenectomy developed SARS-CoV-2 infection; their outcomes were compared to those of a similar group in which the postoperative outcomes were uneventful. RESULTS: There were no significant differences between the two groups in terms of pre- and intraoperative outcomes; however, all of the three cases who developed SARS-CoV-2 infection postoperatively required re-admission in the intensive care unit and a longer hospital in stay. The overall mortality rate was null. CONCLUSION: Patients submitted to pancreatoduodenectomy for pancreatic head cancer who develop SARS-COV-2 infection postoperatively need a more appropriate supportive care; however, the overall mortality does not appear to increase, justifying, in this way, the continuation of programmed oncological of surgeries. Copyright
BACKGROUND/AIM: The aim of this study is to report a case series of three patients who developed postoperative severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) infection, although the initial tests were negative. PATIENTS AND METHODS: Between April and September 2020, three patients submitted to pancreatoduodenectomy developed SARS-CoV-2 infection; their outcomes were compared to those of a similar group in which the postoperative outcomes were uneventful. RESULTS: There were no significant differences between the two groups in terms of pre- and intraoperative outcomes; however, all of the three cases who developed SARS-CoV-2 infection postoperatively required re-admission in the intensive care unit and a longer hospital in stay. The overall mortality rate was null. CONCLUSION:Patients submitted to pancreatoduodenectomy for pancreatic head cancer who develop SARS-COV-2 infection postoperatively need a more appropriate supportive care; however, the overall mortality does not appear to increase, justifying, in this way, the continuation of programmed oncological of surgeries. Copyright
Authors: Anita Balakrishnan; Mickael Lesurtel; Ajith K Siriwardena; Stefan Heinrich; Alejandro Serrablo; Marc G H Besselink; Mert Erkan; Bodil Andersson; Wojciech G Polak; Andrea Laurenzi; Stefan W M Olde Damink; Frederik Berrevoet; Isabella Frigerio; Jose M Ramia; Thomas K Gallagher; Susanne Warner; Shailesh V Shrikhande; Rene Adam; Martin D Smith; Kevin C Conlon Journal: HPB (Oxford) Date: 2020-06-10 Impact factor: 3.647
Authors: Ching-Wei D Tzeng; Hop S Tran Cao; Christina L Roland; Mediget Teshome; Brian K Bednarski; Naruhiko Ikoma; Paul H Graham; Emily Z Keung; Christopher P Scally; Matthew H G Katz; Jeffrey E Gershenwald; Jeffrey E Lee; Jean-Nicolas Vauthey Journal: Surg Oncol Date: 2020-04-28 Impact factor: 3.279
Authors: Ali Aminian; Saeed Safari; Abdolali Razeghian-Jahromi; Mohammad Ghorbani; Conor P Delaney Journal: Ann Surg Date: 2020-07 Impact factor: 13.787
Authors: Urszula Abramczyk; Maciej Nowaczyński; Adam Słomczyński; Piotr Wojnicz; Piotr Zatyka; Aleksandra Kuzan Journal: Int J Mol Sci Date: 2022-01-13 Impact factor: 5.923